Research Papers

25 of 1903 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Integration of pan-omics technologies and three-dimensional in vitro tumor models: an approach toward drug discovery an…
Jose A; Kulkarni P; Thilakan J; Munisamy M; Malhotra AG; Singh J; Kumar A; Rangnekar VM; Arya N; Rao M.
Mol Cancer (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Activation of the PI3K/AKT signaling pathway by ARNTL2 enhances cellular glycolysis and sensitizes pancreatic adenocarc…
Ge W; Wang Y; Quan M; Mao T; Bischof EY; Xu H; Zhang X; Li S; Yue M; Ma J; Yang H; Wang L; Yu Z; Wang L; Cui J.
Mol Cancer (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
circNOX4 activates an inflammatory fibroblast niche to promote tumor growth and metastasis in NSCLC via FAP/IL-6 axis.
Zhao Y; Jia Y; Wang J; Chen X; Han J; Zhen S; Yin S; Lv W; Yu F; Wang J; Xu F; Zhao X; Liu L.
Mol Cancer (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Resistance of HNSCC cell models to pan-FGFR inhibition depends on the EMT phenotype associating with clinical outcome.
Broghammer F; Korovina I; Gouda M; Celotti M; van Es J; Lange I; Brunner C; Mircetic J; Coppes RP; Gires O; Dahl A; Seifert M; Cordes N.
Mol Cancer (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
CircPCNXL2 promotes tumor growth and metastasis by interacting with STRAP to regulate ERK signaling in intrahepatic cho…
Liu S; Wang Y; Wang T; Shi K; Fan S; Li C; Chen R; Wang J; Jiang W; Zhang Y; Chen Y; Xu X; Yu Y; Li C; Li X.
Mol Cancer (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Liquid biopsy in T-cell lymphoma: biomarker detection techniques and clinical application.
Huang Z; Fu Y; Yang H; Zhou Y; Shi M; Li Q; Liu W; Liang J; Zhu L; Qin S; Hong H; Liu Y.
Mol Cancer (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
A novel peptide PDHK1-241aa encoded by circPDHK1 promotes ccRCC progression via interacting with PPP1CA to inhibit AKT …
Huang B; Ren J; Ma Q; Yang F; Pan X; Zhang Y; Liu Y; Wang C; Zhang D; Wei L; Ran L; Zhao H; Liang C; Wang X; Wang S; Li H; Ning H; Ran A; Li W; Wang Y; Xiao B.
Mol Cancer (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Pan-cancer characterization of cell-free immune-related miRNA identified as a robust biomarker for cancer diagnosis.
Wu P; Zhang C; Tang X; Li D; Zhang G; Zi X; Liu J; Yin E; Zhao J; Wang P; Wang L; Li R; Wu Y; Sun N; He J.
Mol Cancer (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Multi-cohort validation of Ascore: an anoikis-based prognostic signature for predicting disease progression and immunot…
Xie T; Peng S; Liu S; Zheng M; Diao W; Ding M; Fu Y; Guo H; Zhao W; Zhuang J.
Mol Cancer (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Role of a novel circRNA-CGNL1 in regulating pancreatic cancer progression via NUDT4-HDAC4-RUNX2-GAMT-mediated apoptosis.
Yuan H; Chen C; Li H; Qu G; Chen L; Liu Y; Zhang Y; Zhao Q; Lian C; Ji A; Hou X; Liu X; Jiang K; Zhu Y; He Y.
Mol Cancer (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Mapping cancer biology in space: applications and perspectives on spatial omics for oncology.
Lee S; Kim G; Lee J; Lee AC; Kwon S.
Mol Cancer (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
LINC01852 inhibits the tumorigenesis and chemoresistance in colorectal cancer by suppressing SRSF5-mediated alternative…
Bian Z; Yang F; Xu P; Gao G; Yang C; Cao Y; Yao S; Wang X; Yin Y; Fei B; Huang Z.
Mol Cancer (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Nasopharyngeal carcinoma: current views on the tumor microenvironment's impact on drug resistance and clinical outcomes.
Liu H; Tang L; Li Y; Xie W; Zhang L; Tang H; Xiao T; Yang H; Gu W; Wang H; Chen P.
Mol Cancer (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Tumor-derived small extracellular vesicles in cancer invasion and metastasis: molecular mechanisms, and clinical signif…
Zhang C; Qin C; Dewanjee S; Bhattacharya H; Chakraborty P; Jha NK; Gangopadhyay M; Jha SK; Liu Q.
Mol Cancer (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Aberrant R-loop-mediated immune evasion, cellular communication, and metabolic reprogramming affect cancer progression:…
Zhang S; Liu Y; Sun Y; Liu Q; Gu Y; Huang Y; Zeng Z; Tang F; Ouyang Y.
Mol Cancer (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Multifaceted roles for BCL3 in cancer: a proto-oncogene comes of age.
Seaton G; Smith H; Brancale A; Westwell AD; Clarkson R.
Mol Cancer (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
CircPPAP2B controls metastasis of clear cell renal cell carcinoma via HNRNPC-dependent alternative splicing and targeti…
Zheng Z; Zeng X; Zhu Y; Leng M; Zhang Z; Wang Q; Liu X; Zeng S; Xiao Y; Hu C; Pang S; Wang T; Xu B; Peng P; Li F; Tan W.
Mol Cancer (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
N6-methyladenosine-modified circPLPP4 sustains cisplatin resistance in ovarian cancer cells via PIK3R1 upregulation.
Li H; Lin R; Zhang Y; Zhu Y; Huang S; Lan J; Lu N; Xie C; He S; Zhang W.
Mol Cancer (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effecti…
Gammelgaard OL; Terp MG; Kirkin AF; Johansen S; Traynor S; Vever H; Guldberg P; Kodahl AR; Gjerstorff MF; Ditzel HJ.
Mol Cancer (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Targeting CRAF kinase in anti-cancer therapy: progress and opportunities.
Wang P; Laster K; Jia X; Dong Z; Liu K.
Mol Cancer (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Acidosis-mediated increase in IFN-γ-induced PD-L1 expression on cancer cells as an immune escape mechanism in solid tum…
Knopf P; Stowbur D; Hoffmann SHL; Hermann N; Maurer A; Bucher V; Poxleitner M; Tako B; Sonanini D; Krishnamachary B; Sinharay S; Fehrenbacher B; Gonzalez-Menendez I; Reckmann F; Bomze D; Flatz L; Kramer D; Schaller M; Forchhammer S; Bhujwalla ZM; Quintanilla-Martinez L; Schulze-Osthoff K; Pagel MD; Fransen MF; Röcken M; Martins AF; Pichler BJ; Ghoreschi K; Kneilling M.
Mol Cancer (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
USP13 drives lung squamous cell carcinoma by switching lung club cell lineage plasticity.
Kwon J; Zhang J; Mok B; Allsup S; Kim C; Toretsky J; Han C.
Mol Cancer (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Extracellular vesicles remodel tumor environment for cancer immunotherapy.
Yue M; Hu S; Sun H; Tuo B; Jia B; Chen C; Wang W; Liu J; Liu Y; Sun Z; Hu J.
Mol Cancer (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain …
Zhang Y; Patel RP; Kim KH; Cho H; Jo JC; Jeong SH; Oh SY; Choi YS; Kim SH; Lee JH; Angelos M; Guruprasad P; Cohen I; Ugwuanyi O; Lee YG; Pajarillo R; Cho JH; Carturan A; Paruzzo L; Ghilardi G; Wang M; Kim S; Kim SM; Lee HJ; Park JH; Cui L; Lee TB; Hwang IS; Lee YH; Lee YJ; Porazzi P; Liu D; Lee Y; Kim JH; Lee JS; Yoon DH; Chung J; Ruella M.
Mol Cancer (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Targeting MHC-I molecules for cancer: function, mechanism, and therapeutic prospects.
Wu X; Li T; Jiang R; Yang X; Guo H; Yang R.
Mol Cancer (Unknown)
Published: 2023
3/6 Transparent
Funding Declared